Roland Martin, MD
Head of nims Email: roland.martin@usz.ch Tel (secretary): +41 44 255 12 18 |
Roland Martin is full professor for neurology and neuroimmunology at the University Zürich and heads the Neuroimmunology and Multiple Sclerosis Research Section and MS outpatient clinic at the University Hospital Zurich. R. Martin trained in medicine, and specialized in neurology at the University Würzburg. He pursued post-doctoral fellowships in immunology, virology and neuroimmunology in Würzburg and at the Neuroimmunology Branch, National Institutes of Health (NIH), Bethesda, USA, where he worked as tenured senior investigator until 2005. Subsequently, he held full professorships in Barcelona (Vall D´Hebron University Hospital), Hamburg (Director of the Institute for Neuroimmunology and Clinical MS Research, University Hamburg) and now in Zurich. The main interests of his group are disease mechanisms of multiple sclerosis (MS), cellular immunology, disease mechanisms of JC polyoma virus-mediated progressive multifocal leukoencephalopathy (PML) and developing novel treatments for MS and PML besides providing care for MS patients in one of the largest MS centers in Switzerland. He has received several awards, published over 370 scientific articles and filed numerous patents in the above areas. He and his group developed more than 10 projects from idea to early clinical proof-of-concept trials. One of these projects (Daclizumab, an anti-CD25 monoclonal antibody; Zinbryta®) was just approved for the treatment of MS by EMA, FDA and Swissmedic. He is a member of the Kuratorium of the Jung Foundation for Science, Hamburg, of the core faculty of the Wyss Translational Center Zurich, a cofounder of the Drug Discovery Network Zurich (DDNZ), a cofounder of the Therapy Development Accelerator (TDA) at the University Zurich, and a cofounder and co-owner of Cellerys AG, a startup company specializing in tolerance induction.
|
Third Party Funding
Sven Schippling, MD
Group leader MINDS Email: Sven.schippling@usz.ch Tel: +41 44 255 55 40 |
Sven Schippling was appointed to the ‘Multimodal Imaging in Neurology’ Professorship at the University of Zurich in August 2015. He is a senior neurologist and head of the Neuroimmunology outpatient unit at the Department of Neurology, University Hospital and University of Zurich, Switzerland. He is a Co-Director of the Clinical Research Priority Program on Multiple Sclerosis (CRPP-MS) of the University of Zurich and a Senior Group Leader at the Neuroscience Center Zurich, Federal Institute of Technology (ETH ), Zurich.
Sven Schippling received his medical degree from the University of Hamburg, Germany. He has completed post-doctoral research fellowships at the Institute for Molecular Cell Biology Hamburg-Eppendorf, and at the Institute of Neurology, University College London, UK from 2005-2006. He received his board certification in neurology in 2008. Sven Schippling’s research interests centre on structural and quantitative magnetic resonance imaging (MRI) and optical coherence tomography in MS and neuromyelitis optica spectrum disorders (NMOSD), the development of novel imaging-based outcome measures for Phase II proof-of-concept clinical trials in MS, and systems electrophysiology/transcranial magnetic stimulation. His research is supported by the Clinical Research Priority Program of the University of Zurich, the Betty and David Koetser Foundation for Brain Research and The Swiss MS Society. He is a founding member of the Neuromyelitis Optica Study Group (NEMOS) and sits on the International Clinical Consortium of the Guthy Jackson Charitable Foundation for NMOSD Research (CA, USA). He is a member of the scientific advisory board of the Swiss MS Society and the Drug Discovery Network Zurich (DDNZ). |
Third Party Funding
Andreas Lutterotti, MD
Head of Experimental Therapies Research Email: andreas.lutterotti@usz.ch Tel: +41 44 255 49 84 |
Andreas Lutterotti is assistant professor for "Experimental Therapy Research in Multiple Sclerosis and Other Neurological Diseases" at the University of Zurich since August 2014, as well as a senior physician at the Department of Neurology, Section Neuroimmunology and MS Research (nims), University Hospital Zurich. He has earned his medical doctor's degree at the Medical University in the Clinical Department of Neurology, Innsbruck was thereafter PostDoc and resident until 2012. During this time, he pursued a Alexander von Humboldt fellowship at the Institute of Neuroimmunology and Clinical Multiple Sclerosis Research in Hamburg. Subsequently, he returned to the Clinical Department of Neurology, Innsbruck, was certified in Neurology in 2012 and continued to work as a Senior Scientist. Andreas Lutterotti was appointed as assistant professor at the Department of Neurology, University Hospital Zurich, in August 2014. His core expertise is the development and implementation of experimental therapies in the field of multiple sclerosis and other autoimmune diseases. His research is supported by the UZH CRPP MS, the Wyss Translational Center Zurich and the Swiss MS Society.
|
Third Party Funding
Mireia Sospedra Ramos, PhD
Head of nims laboratory Email: mireia.sospedraramos@usz.ch Tel: +41 44 255 39 05 |
Mireia Sospedra studied biology at the University of Barcelona and received her PhD on the induction of central tolerance to peripheral antigens at the Autonomous University of Barcelona under the supervision of Dr. Ricardo Pujol Borrell. After her PhD she moved to Paris in 1999 where she pursued a first postdoc at la Pitié-Salpêtrière hospital under the supervision of Dr. Alain Trautmann studying the interaction between T cells and dendritic cells in the absence of nominal antigen. In April 2001 she obtained a competitive fellowship from the National Institute of Neuological Diseases and Stroke (NINDS; at the National Institute of Health (NIH)) and moved to USA for a second postdoc. She started working in MS under the supervision of Dr. Roland Martin with a focus on the identification of new autoantigens. After four years at NIH, she returned to Barcelona 2005 with a career development grant/assistant professorship of the Catalan Institute for Research and Advanced Studies (ICREA) at the Neuroimmunology Unit (Vall d’Hebron Hospital) directed by Dr. Xavier Montalban. In 2007 she moved to Hamburg and started working at Institute of Neuroimmunology and Multiple Sclerosis Research (Center of Molecular Neurobiology Hamburg, University Hospital Eppendorf) as independent investigator studying T cell specificity in MS and also the role of neutrophils. Since September 2011 she heads the Laboratory of Neuroimmunology at the Neuroimmunology and Multiple Sclerosis Research Section at the Neurology Clinic, University Hospital Zurich, and University of Zurich.
|
Third Party Funding
